Both in Pharmaceuticals
Gossamer Bio vs Nomad Power Solutions
Over the past year GOSS returned −13.5% and NMAD returned −0.6%; their daily moves had a correlation of 0.22.
GOSS −13.5% NMAD −0.6%Growth of $1, one year, split-adjusted
| Metric | GOSS | NMAD |
|---|---|---|
| Price | $9.28 | $3.52 |
| Market cap | $56.8M | $56.7M |
| Today | −1.80% | +1.44% |
| 1 month | −12.9% | −12.3% |
| 6 months | −65.5% | — |
| Year to date | −96.3% | — |
| 1 year | −95.3% | — |
| Revenue growth (YoY) | −19.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 182.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | — |
| Net cash | $20.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 1,265.9% | — |
| Short % of float | 24.9% | 11.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).